EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Urinary and Faecal Amino‐Acids as Biomarkers for Colorectal Neoplasia in Lynch Syndrome—A Prospective Longitudinal Study

Roza C M Opperman iD, Elsa L S A van Liere iD, Animesh Acharjee iD, Sudip Mondal, Eduard A Struys, Andreas Antoniadis, Jasmijn E B de Boer, Shivra R Siriram, Abdellatif Bakkali, Sofie Bosch, Maarten A J M Jacobs, Jan Jacob Koornstra und 7 weitere

International Journal of Cancer · 22.08.2026

DOI: 10.1002/ijc.70715 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, online erschienen am 22.08.2026. Verfasst von Roza C M Opperman und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Feces, Colorectal Neoplasms, Hereditary Nonpolyposis, Biomarkers, Tumor, Colorectal Neoplasms. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MDL Fonds, Dutch Lynch Polyposis patient association, Louise Vehmeijer Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In Lynch syndrome, colonoscopy surveillance for colorectal cancer (CRC) is burdensome and post‐colonoscopy CRCs still occur. Unlike the faecal immunochemical test (FIT), gut metabolomic alterations including amino‐acids have shown potential as non‐invasive biomarkers for detecting both advanced and non‐advanced sporadic colorectal neoplasia. We aimed to evaluate the potential of faecal and urinary amino‐acids to refine colonoscopy surveillance in Lynch syndrome. Individuals with Lynch syndrome collected faeces and urine 3 months before and 3–6 months after surveillance colonoscopy. Individuals with and without relevant neoplasia (defined as CRC, adenomas and advanced serrated polyps) were matched based on age, sex, smoking, and diet. Using liquid chromatography–tandem mass spectrometry and Random Forest classification, we assessed the diagnostic performance for relevant neoplasia of 20 faecal amino‐acids (± positive FIT at 2.55 μg Hb/g faeces) and 20 urinary amino‐acids. Among the 150 included individuals (118 collected faeces and 64 urine), 3% had CRC, 5% advanced adenomas, 3% advanced serrated polyps and 40% non‐advanced adenomas at colonoscopy. In individuals with relevant neoplasia, faecal taurine and urinary citrulline, threonine and ornithine were elevated. Amino‐acids showed 80% (faeces) and 88% (urine) sensitivity for relevant neoplasia, with higher specificity in urine (60%) than faeces (33%). Adding FIT‐results to amino‐acids outcomes did not improve diagnostic accuracy. After polypectomy, several faecal and urinary amino acids shifted towards levels of individuals without neoplasia. This exploratory study in Lynch syndrome highlights faecal and urinary amino acids as promising non‐invasive biomarkers for postponing colonoscopy and follow‐up after polypectomy, although these findings require external validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FecesColorectal Neoplasms, Hereditary NonpolyposisBiomarkers, TumorColorectal NeoplasmsAmino AcidsHumansFemaleMaleProspective StudiesMiddle AgedLongitudinal StudiesColonoscopyAdenomaAdultAgedEarly Detection of Cancer

Stichwörter der Autor:innen

adenomasamino acidsbiomarkerscolorectal cancerlynch syndromesurveillance

Substanzen

Biomarkers, TumorAmino Acids

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam, the Netherlands.
  • Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Amsterdam, the Netherlands.
  • Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • Department of Cancer and Genomic Sciences, School of Medical Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.
  • Department of Laboratory Medicine, Amsterdam University Medical Center, Amsterdam, the Netherlands.
  • Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands.

ORCID-Profile: Roza C M Opperman, Elsa L S A van Liere, Animesh Acharjee, Manon C W Spaander

Förderung

  • MDL Fonds
  • Dutch Lynch Polyposis patient association
  • Louise Vehmeijer Foundation
  • Vaillant Fonds

Zitieren

APA

Opperman, R. C. M., van Liere, E. L. S. A., Acharjee, A., Mondal, S., Struys, E. A., Antoniadis, A., de Boer, J. E. B., Siriram, S. R., Bakkali, A., Bosch, S., Jacobs, M. A. J. M., Koornstra, J. J., Kuijvenhoven, J. P., van Leerdam, M. E., Spaander, M. C. W., de Meij, T. G. J., Dekker, E., Ramsoekh, D., & de Boer, N. K. H. (2026). Urinary and Faecal Amino‐Acids as Biomarkers for Colorectal Neoplasia in Lynch Syndrome—A Prospective Longitudinal Study. International Journal of Cancer. https://doi.org/10.1002/ijc.70715

Vancouver

Opperman RCM, van Liere ELSA, Acharjee A, Mondal S, Struys EA, Antoniadis A, et al. Urinary and Faecal Amino‐Acids as Biomarkers for Colorectal Neoplasia in Lynch Syndrome—A Prospective Longitudinal Study. International Journal of Cancer. 2026. doi:10.1002/ijc.70715

BibTeX
@article{Opperman2026,
  author = {Opperman, Roza C M and van Liere, Elsa L S A and Acharjee, Animesh and Mondal, Sudip and Struys, Eduard A and Antoniadis, Andreas and de Boer, Jasmijn E B and Siriram, Shivra R and Bakkali, Abdellatif and Bosch, Sofie and Jacobs, Maarten A J M and Koornstra, Jan Jacob and Kuijvenhoven, Johan P and van Leerdam, Monique E and Spaander, Manon C W and de Meij, Tim G J and Dekker, Evelien and Ramsoekh, Dewkoemar and de Boer, Nanne K H},
  title = {Urinary and Faecal Amino‐Acids as Biomarkers for Colorectal Neoplasia in Lynch Syndrome—A Prospective Longitudinal Study},
  journal = {International Journal of Cancer},
  year = {2026},
  doi = {10.1002/ijc.70715}
}
Kostenlos starten →